DivestmentMay 8, 2026, 06:02 AM
McKesson to Separate Medical-Surgical Unit; Apollo Invests $1.25B
AI Summary
McKesson Corporation announced a new four-segment reporting structure in fiscal 2026, comprising North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company intends to separate its Medical-Surgical Solutions segment into an independent company, with Apollo Funds acquiring a 13% minority ownership interest for approximately $1.25 billion. Additionally, McKesson completed the sale of its Norwegian operations during fiscal 2026, reflecting strategic initiatives to focus on core healthcare businesses.
Key Highlights
- Implemented new four-segment reporting structure in fiscal 2026.
- Intends to separate Medical-Surgical Solutions segment into an independent company.
- Apollo Funds to acquire 13% minority stake in Medical-Surgical Solutions for $1.25 billion.
- Completed sale of Norwegian operations during fiscal 2026.
- North American Pharmaceutical segment distributes drugs in U.S. and Canada.
- Oncology & Multispecialty segment includes specialty drug distribution and U.S. Oncology Network.
- Prescription Technology Solutions addresses medication access and affordability.
- Medical-Surgical Solutions provides supplies to non-acute settings in the U.S.